Archives: Speakers

Eleanor McLaurin, Solution Specialist for Medidata has spent over 20 years in the Life Sciences industry. Eleanor supports organisations to create efficiencies throughout the clinical development and regulatory lifecycle through adoption of transformational technologies and data driven clinical and regulatory development approaches. Eleanor has spent the last 6 years working with organisations to leverage practical applications of AI and to implement data strategies which enable reliable generation of evidence and insights for internal oversight as well as for regulatory inspections and submissions.

Medical Doctor, Clinical Pharmacologist and Medical Director of VCTC, a patient centric clinical trial site located in the UK and Spain, dedicated to making clinical research accessible.

Isabel Al-Dhahir is a principal analyst in GlobalData’s Strategic Intelligence team where she advises clients on the disruptive impact of various emerging technologies including artificial intelligence, robotics, and quantum computing.

Gunilla Andrew-Nielsen has held her current position as Head of Clinical Trial and Special Permission at the MPA in Sweden during seven years. Since the early 1990s, she has held various positions within global R&D in the pharma industry including project and training management and later as Director of Quality Assurance.

Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group.

During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio.

Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

With a keen eye for Strategic Vision, Jonathan has been at the forefront of advancing analytical capabilities, particularly in site intelligence, operational metrics, and quality indicators. With a prowess in Digital Transformation has been instrumental in the on-time delivery and precision of a diverse suite of predictive models, leveraging ML/AI and Generative AI technologies.